OpenURL Connection Search

Select item for more details and to access through your institution.

Effects of Dapagliflozin and Combination Therapy With Exenatide on Food-Cue Induced Brain Activation in Patients With Type 2 Diabetes.
Published in:
Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 6, p. e2590, doi. 10.1210/clinem/dgac043
By:
- van Ruiten, Charlotte C.;
- Veltman, Dick J.;
- Schrantee, Anouk;
- van Bloemendaal, Liselotte;
- Barkhof, Frederik;
- Kramer, Mark H. H.;
- Nieuwdorp, Max;
- IJzerman, Richard G.
Publication type:
Article
Combination therapy with exenatide decreases the dapagliflozin‐induced changes in brain responses to anticipation and consumption of palatable food in patients with type 2 diabetes: A randomized controlled trial.
Published in:
Diabetes, Obesity & Metabolism, 2022, v. 24, n. 8, p. 1588, doi. 10.1111/dom.14732
By:
- van Ruiten, Charlotte C.;
- Veltman, Dick J.;
- Wijdeveld, Madelief;
- ten Kulve, Jennifer S;
- Kramer, Mark H. H.;
- Nieuwdorp, Max;
- IJzerman, Richard G.
Publication type:
Article
Mechanisms underlying the blood pressure lowering effects of dapagliflozin, exenatide, and their combination in people with type 2 diabetes: a secondary analysis of a randomized trial.
Published in:
Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01492-x
By:
- van Ruiten, Charlotte C.;
- Smits, Mark M.;
- Kok, Megan D.;
- Serné, Erik H.;
- van Raalte, Daniël H.;
- Kramer, Mark H. H.;
- Nieuwdorp, Max;
- IJzerman, Richard G.
Publication type:
Article
Brain Activation in Response to Low-Calorie Food Pictures: An Explorative Analysis of a Randomized Trial With Dapagliflozin and Exenatide.
Published in:
Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.863592
By:
- van Ruiten, Charlotte C.;
- Veltman, Dick J.;
- Nieuwdorp, Max;
- IJzerman, Richard G.
Publication type:
Article
Erratum. SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management. Diabetes Care 2018;41:1543-1556.
Published in:
2019
By:
- van Baar, Michaël J B;
- van Ruiten, Charlotte C;
- Muskiet, Marcel H A;
- van Bloemendaal, Liselotte;
- IJzerman, Richard G;
- van Raalte, Daniël H
Publication type:
Journal Article
SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management.
Published in:
2018
By:
- van Baar, Michael J. B.;
- van Ruiten, Charlotte C.;
- Muskiet, Marcel H. A.;
- van Bloemendaal, Liselotte;
- IJzerman, Richard G.;
- van Raalte, Daniel H.;
- van Baar, Michaël J B;
- van Raalte, Daniël H
Publication type:
journal article
Personalized Dietary Advice to Increase Protein Intake in Older Adults Does Not Affect the Gut Microbiota, Appetite or Central Processing of Food Stimuli in Community-Dwelling Older Adults: A Six-Month Randomized Controlled Trial.
Published in:
Nutrients, 2023, v. 15, n. 2, p. 332, doi. 10.3390/nu15020332
By:
- Fluitman, Kristina S.;
- Wijdeveld, Madelief;
- Davids, Mark;
- van Ruiten, Charlotte C.;
- Reinders, Ilse;
- Wijnhoven, Hanneke A. H.;
- Keijser, Bart J. F.;
- Visser, Marjolein;
- Nieuwdorp, Max;
- IJzerman, Richard G.
Publication type:
Article

Found: 7

Effects of Dapagliflozin and Combination Therapy With Exenatide on Food-Cue Induced Brain Activation in Patients With Type 2 Diabetes.

Combination therapy with exenatide decreases the dapagliflozin‐induced changes in brain responses to anticipation and consumption of palatable food in patients with type 2 diabetes: A randomized controlled trial.

Mechanisms underlying the blood pressure lowering effects of dapagliflozin, exenatide, and their combination in people with type 2 diabetes: a secondary analysis of a randomized trial.

Brain Activation in Response to Low-Calorie Food Pictures: An Explorative Analysis of a Randomized Trial With Dapagliflozin and Exenatide.

Erratum. SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management. Diabetes Care 2018;41:1543-1556.

SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management.

Personalized Dietary Advice to Increase Protein Intake in Older Adults Does Not Affect the Gut Microbiota, Appetite or Central Processing of Food Stimuli in Community-Dwelling Older Adults: A Six-Month Randomized Controlled Trial.